@Endless Be good
PAB- watch for the announcement.
Possible groundbreaker in Global Deoxymab cancer breakthrough.For a $4MV Aussie Biotech, globally this could be enormous.
""Patrys believes that Deoxymab, and its sister antibody, 5C6, may have application across a wide range of malignancies such as gliomas, melanomas, prostate, breast, pancreatic and ovarian cancers."(WORLDWIDE).
.8cps being eaten as i type
- Forums
- ASX - Day Trading
- Daytrading October 7 afternoon
Daytrading October 7 afternoon, page-61
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online